0

Gastroenterology/Hepatology Collection
 241-260 of 2627 Articles
Therapeutics |  May/Jun 2002
Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease
Gurinder Luthra, MD; P. Jay Pasricha, MD
Ann Intern Med. 2002;136(3):92. doi:10.7326/ACPJC-2002-136-3-092
Therapeutics |  May/Jun 2002
Review: Hemoccult screening reduces death from colorectal cancer in average-risk patients > 50 years of age
Robert Fletcher, MD, MSc
Ann Intern Med. 2002;136(3):91. doi:10.7326/ACPJC-2002-136-3-091
Brief Communications |  16 April 2002
Severe Hepatotoxicity Associated with the Dietary Supplement LipoKinetix
Joya T. Favreau, MD; Mina L. Ryu, MD; Glenn Braunstein, MD; et al.
Ann Intern Med. 2002;136(8):590-595. doi:10.7326/0003-4819-136-8-200204160-00008
Editorials |  19 March 2002
“Did This Drug Cause My Patient's Hepatitis?” and Related Questions
David W. Nierenberg, MD
Ann Intern Med. 2002;136(6):480-483. doi:10.7326/0003-4819-136-6-200203190-00013
Ideas and Opinions |  19 March 2002
Deconstructing the Placebo Effect and Finding the Meaning Response
Daniel E. Moerman, PhD; Wayne B. Jonas, MD
Ann Intern Med. 2002;136(6):471-476. doi:10.7326/0003-4819-136-6-200203190-00011
Brief Communications |  19 March 2002
Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy
Louis D. May, MD; Jay H. Lefkowitch, MD; Michael T. Kram, MD; et al.
Ann Intern Med. 2002;136(6):449-452. doi:10.7326/0003-4819-136-6-200203190-00008
Articles |  5 March 2002
Survival Associated with 5-Fluorouracil–Based Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer
Vijaya Sundararajan, MD, MPH; Nandita Mitra, PhD; Judith S. Jacobson, DrPH; et al.
Ann Intern Med. 2002;136(5):349-357. doi:10.7326/0003-4819-136-5-200203050-00007
Editorials |  19 February 2002
Second Primary Colorectal Cancer: The Consequence of Management Failure at Several Potential Levels
Paul J. Limburg, MD, MPH; David A. Ahlquist, MD
Ann Intern Med. 2002;136(4):335-337. doi:10.7326/0003-4819-136-4-200202190-00013
Brief Communications |  19 February 2002
Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C
Yngve Falck-Ytter, MD; Hemangi Kale, MD; Kevin D. Mullen, MD; et al.
Ann Intern Med. 2002;136(4):288-292. doi:10.7326/0003-4819-136-4-200202190-00008
Articles |  19 February 2002
The Stool Antigen Test for Detection of Helicobacter pylori after Eradication Therapy
Dino Vaira, MD; Nimish Vakil, MD; Marcello Menegatti, MD; et al.
Ann Intern Med. 2002;136(4):280-287. doi:10.7326/0003-4819-136-4-200202190-00007
Articles |  19 February 2002
Surveillance for Second Primary Colorectal Cancer after Adjuvant Chemotherapy: An Analysis of Intergroup 0089
Robert J. Green, MD, MSCE; Joshua P. Metlay, MD, PhD; Kathleen Propert, ScD; et al.
Ann Intern Med. 2002;136(4):261-269. doi:10.7326/0003-4819-136-4-200202190-00005
Brief Communications |  15 January 2002
Reporting on Statistical Methods To Adjust for Confounding: A Cross-Sectional Survey
Marcus Müllner, MD; Hugh Matthews, BSc, MBBS; Douglas G. Altman, DSc
Ann Intern Med. 2002;136(2):122-126. doi:10.7326/0003-4819-136-2-200201150-00009
Articles |  15 January 2002
Initial Evaluation of Rectal Bleeding in Young Persons: A Cost-Effectiveness Analysis
James D. Lewis, MD, MSCE; Alphonso Brown, MD; A. Russell Localio, JD, MS; et al.
Ann Intern Med. 2002;136(2):99-110. doi:10.7326/0003-4819-136-2-200201150-00007
Articles |  1 January 2002
Risk Factors for Helicobacter pylori Resistance in the United States: The Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) Study, 1993–1999
Joette M. Meyer, PharmD; Nancy P. Silliman, PhD; Wenjin Wang, PhD; et al.
Ann Intern Med. 2002;136(1):13-24. doi:10.7326/0003-4819-136-1-200201010-00008
Reviews |  20 November 2001
Diagnosis and Treatment of Perianal Fistulas in Crohn Disease
David A. Schwartz, MD; John H. Pemberton, MD; William J. Sandborn, MD
Ann Intern Med. 2001;135(10):906-918. doi:10.7326/0003-4819-135-10-200111200-00011
Brief Communications |  6 November 2001
Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B Vaccination
Yen-Hsuan Ni, MD, PhD; Mei-Hwei Chang, MD; Li-Min Huang, MD, PhD; et al.
Ann Intern Med. 2001;135(9):796-800. doi:10.7326/0003-4819-135-9-200111060-00009
Articles |  6 November 2001
Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis
Uri Ladabaum, MD, MS; Cathy Lee Chopra, MD, MS; Grace Huang, MD, MS; et al.
Ann Intern Med. 2001;135(9):769-781. doi:10.7326/0003-4819-135-9-200111060-00007
Articles |  6 November 2001 FREE
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
Brian J. McMahon, MD; Peter Holck, PhD; Lisa Bulkow, MS; et al.
Ann Intern Med. 2001;135(9):759-768. doi:10.7326/0003-4819-135-9-200111060-00006
Quality Indicators for Assessing Care of Vulnerable Elders |  16 October 2001 FREE
Quality Indicators for Pain Management in Vulnerable Elders
Joshua Chodosh, MD, MSHS; Bruce A. Ferrell, MD; Paul G. Shekelle, MD, PhD; et al.
Ann Intern Med. 2001;135(8_Part_2):731-735. doi:10.7326/0003-4819-135-8_Part_2-200110161-00012
Articles |  16 October 2001
Cost-Effectiveness of Microsatellite Instability Screening as a Method for Detecting Hereditary Nonpolyposis Colorectal Cancer
Scott D. Ramsey, MD, PhD; Lauren Clarke, MS; Ruth Etzioni, PhD; et al.
Ann Intern Med. 2001;135(8_Part_1):577-588. doi:10.7326/0003-4819-135-8_Part_1-200110160-00008
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)